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Abstract: Apicomplexan parasites are protozoan organisms that are characterised by complex life
cycles and they include medically important species, such as the malaria parasite Plasmodium and
the causative agents of toxoplasmosis (Toxoplasma gondii) and cryptosporidiosis (Cryptosporidium
spp.). Apicomplexan parasites can infect one or more hosts, in which they differentiate into several
morphologically and metabolically distinct life cycle stages. These developmental transitions rely on
changes in gene expression. In the last few years, the important roles of different members of the
ApiAP2 transcription factor family in regulating life cycle transitions and other aspects of parasite
biology have become apparent. Here, we review recent progress in our understanding of the different
members of the ApiAP2 transcription factor family in apicomplexan parasites.
Keywords: Apicomplexa; Plasmodium; Toxoplasma; Cryptosporidium; malaria; gene regulation;
transcription factor; ApiAP2; differentiation
1. Introduction
Apicomplexan parasites, like Plasmodium spp., Toxoplasma gondii, or Cryptosporidium spp. cause
devastating diseases in humans and their eradication is still far away. Plasmodium falciparum parasites
alone accounted for about 435,000 deaths in 2017 and small children under the age of five, in particular,
are affected by the disease [1]. T. gondii causes many deaths in immunocompromised patients and it
has detrimental effects when newly acquired during pregnancy [2], and Cryptosporidium spp. are one
of the leading causes of infant diarrhoea in developing countries [3]. With emerging drug resistance
in Plasmodium and other apicomplexan parasites, treatment options are becoming limited [4,5],
and it is clear that there is a need for better and innovative drugs. This will be greatly aided by
a profound understanding of the parasites’ biology. The apicomplexan parasites have complex life
cycles, which are marked by several differentiation steps that are associated with significant switches in
the transcriptome [6–10]. In Plasmodium and Toxoplasma, epigenetic regulation via histone modifications
and histone variants has been implicated in the control of gene expression (reviewed in [11]), but also,
generally, specific transcription factors (TFs) are of major importance in the developmental regulation
of transcription in eukaryotes [12]. For a long time, only few conserved DNA binding domains of
specific TFs were identified in the apicomplexan lineage, including myb (myeloblastosis), PREBP
(Prx Regulatory Element binding protein), HMGB (high mobility group b), C2H2 zinc fingers, and
E2F (only in Cryptosporidium) domains [13–20]. However, in 2005, Balaji et al. first described a class
of putative TFs in Apicomplexa that carried a domain presenting similarity to the Apetala2/ERF
(ethylene response factor) (AP2/ERF) integrase DNA binding domain, which is present in many plant
TFs [21,22]. Thus, this novel family of putative TFs was dubbed ApiAP2 (apicomplexan AP2). The
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putative acquisition of an ancestral AP2/ERF TF from the plant lineage by horizontal gene transfer
was in line with the hypothesis that a red alga of rhodophyte origin was an endosymbiont in the
apicomplexan parasites ancestor, from which the apicoplast organelle originated [23–26].
P. falciparum codes for 27 putative ApiAP2 TFs, while in T. gondii and C. parvum, there are more than
60 and 10 ApiAP2 annotated genes, respectively [27]. Some of the ApiAP2 TFs are widely conserved
among the apicomplexan families and their close relative Perkinsus marinus [28], suggesting that
their common chromalveolate ancestor could already have had about 9 to 18 AP2 domain containing
TFs, while the more species specific factors likely evolved through independent lineage-specific
expansion after the divergence of the Apicomplexan species [21,28]. Gene expression data from
P. falciparum and C. parvum indicated that different ApiAP2 family members were expressed in
different stages during parasite development, suggesting that they might be involved in life cycle
progression and differentiation processes, like their plant homologues [21,29]. Numerous studies
have since corroborated this hypothesis and demonstrated the critical importance of ApiAP2 TFs in
apicomplexan biology.
2. Structure of ApiAP2 Transcription Factors
The ApiAP2 TFs can comprise one to four AP2 domains as well as additional functional regions
and they greatly vary in size, from approximately 200 to several thousand amino acids (Figure 1). There
is generally little sequence homology outside of the AP2 domains. Apart from the AP2 domain, other
protein domains that are present in some of the ApiAP2s in Plasmodium spp. include a DNA binding
domain called AT-hook, a zinc finger domain, an Acyl-CoA-N-acetyltransferase domain, as well
as a pentapeptide-repeat-like domain (Figure 1). Several ApiAP2 TFs in P. falciparum additionally
contain a conserved motif that was named the ACDC domain (AP2-coincident domain mainly at the
C-terminus), but the function of this domain is unknown thus far [30].
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Figure 1. Apicomplexan AP2 (ApiAP2)-domain-containig proteins in P. falciparum. The proteins are
organised by size, ApiAP2-domains are marked in red, ACDC (AP2-coincident domain mainly at the
C-terminus) domains in pink, AT hooks in black, zinc finger in blue, Acyl-CoA-N-acyltransferase in
light blue, pentapeptide-repeat-like domains in yellow.
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AP2 domains are about 60 amino acids in size and they normally consist of 3 β-strands and one
C-terminal α-helix that stabilises the β-strands [21,31]. An insert is present between strand 2 and 3 that
might stand out as a hairpin-like structure, which is positively charged. This positive charge probably
enables the nonspecific interaction with the DNA backbone, enhancing the affinity of the ApiAP2
TF to the DNA. When comparing multiple AP2 domains from plants and other organisms, it was
shown that 12 amino acid residues were highly conserved, which are implicated in the formation
of specific DNA contacts with GCC boxes and DNA backbone contact [21]. In plants, the residues
corresponding to R150, R152, W154, E160, R162, R170, and W172 (in the AP2 domain of the plant TF
ATERF) mediate the specific binding to the GCC boxes. In ApiAP2s, the R150 residue is often changed
to be Y or S and the R152 residue, rather, is found to be D or N, with both being more likely to interact
with the amino group of adenine than with guanine. In contrast, the E160 and W172 residues are
maintained as polar amino acids with aromatic residues, indicating that they are less important for
differential sequence specificities. Altogether, this shows that there is a higher variability of binding
and recognition motifs for the ApiAP2 TFs, which may represent specific adaptation to the higher AT
content of the apicomplexan parasites [21]. The crystal structure of PfAP2-Sp/Exp (PF3D7_1466400) in
complex with DNA revealed binding of the double stranded DNA in the major groove of the ApiAP2
factor and the dimerisation of two ApiAP2 domains by domain-swapping of the α-helices, so that
the α-helix from one ApiAP2 aligns with the β-strands of the other ApiAP2 [31]. This dimerization is
probably induced by DNA binding and it is stabilized by disulphide bridges that are formed at the
cysteine residue C76, with a nearby proline residue further facilitating it. Several other residues are
also important for DNA binding; among these were the N72, R74, R88, and S90 [31]. Furthermore,
the AT-hook contributes to DNA binding but in a non-sequence-specific way [31,32].
3. DNA Binding Motifs of ApiAP2 Transcription Factors
The regulation of gene expression by specific TFs is generally mediated by the interaction of
the DNA binding domain with specific DNA motifs that are present in regulatory regions upstream
of the target gene promoters. In P. falciparum, the motifs that were bound by 24 AP2 domains in
20 ApiAP2 TFs were revealed by protein binding microarrays [33,34], and several of these motifs
have been functionally confirmed in subsequent studies [35–38]. These ApiAP2 binding motifs are
largely present in intergenic regions that are upstream of genes, and often more than one motif can
be found clustered together, indicating the combinatorial regulation by ApiAP2 TFs. Several AP2
domains bind similar motifs, such as the CACACA repeat [38], but the different AP2 domains that are
present in single ApiAP2 TFs generally recognise distinct motifs, which could help in restricting the
specificity of the target gene repertoire, despite redundancy in sequence recognition [33]. In line with
the hypothesis that ApiAP2s mediate developmental progression, some of these motifs were enriched
in genes that showed similar expression profiles across the asexual replication cycle and might thus
represent co-regulated target genes of specific ApiAP2s. A study that addressed the accessibility of
DNA motifs during the life cycle using a Tn5 transposase mediated approach (ATACseq) further
supported this concept by identifying sequences that correlated with stage specific gene expression
and that were bound by ApiAP2 TFs [38]. Another study suggested that the accessibility of these
motifs correlates with certain histone modification patterns, linking ApiAP2 factors to epigenetic gene
regulation [39].
Similar to other Apicomplexa, Cryptosporidia show highly regulated gene expression patterns
throughout their intracellular life cycle. Oberstaller et al., 2013 predicted putative TF binding motifs
through the identification of overrepresented motifs in the upstream region of genes with similar
expression patterns [29,34]. The E2F-like motif TGGCGCCA was among these, which could be utilised
by the E2F TFs that are present in Cryptosporidium, but are absent in Plasmodium spp. and other
Apicomplexa. Other motifs included the G-box motif GxGGGG, which was shown to be recognised by
cgd8_810 using protein binding microarrays [29]; the (T/C)GCATGC(A/G) motif that is bound by
cgd2_3490 and was also characterised as binding motif for the PfAP2-EXP and its rodent orthologue
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PbAP2-SP [34]; and the uncharacterised motif (A/C)AACTA [29]. Protein binding microarrays further
showed that the TGCAT motif (also dubbed AP2_1-like) present in the binding site of cgd2_3490
was also recognised by three other ApiAP2-domain-containing proteins. Showing similar binding
redundancy, the CACACA motif was recognised by four different ApiAP2 TFs and the G box motif
was recognised by three different proteins. Interestingly, cgd1_3520 recognised both, the AP2_1-like
and the G-box motif [28]. This suggests a high redundancy of ApiAP2 factors in Cryptosporidium that
may possibly be balanced by the usage of specific E2F TFs in comparison to other Apicomplexa [28].
4. Developmental Transitions during Apicomplexan Life Cycles
The life cycles of Apicomplexan parasites are characterised by several common major
differentiation steps, during which the parasites transition into morphologically and physiologically
very distinct forms: first from sporozoites, which facilitate the transmission to a new host, to asexual
forms that undergo cycles of replication by schizogony. Some of the progeny differentiate to the
sexual forms, male and female gametes, which then fertilize and give rise to the zygote that develops
into an oocyst, in which sporogony occurs (Figure 2). Significantly different gene expression profiles
characterize all these different stages [10,40–54], which will be described in detail for each parasite
genus in the following paragraphs.
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Several species of Anopheles mosquitos transmit Plasmodium parasites. During the bite of an
infected mosquito, sporozoites are injected from the salivary gland into the human bloodstream, from
where they invade hepatocytes (reviewed in [55]). There, the sporozoites develop into the liver schizont
stage and propagate until 10,000–30,000 newly formed merozoites egress into the bloodstream. This
hepatic cycle is then followed by the asexual intraerythrocytic cycle, in which the released merozoites
invade erythrocytes, where they develop from a ring stage form into a trophozoite that undergoes
schizogony. Finally, 16–32 new merozoites egress from the mature schizont and infect new cells,
resulting in the asexual replication cycle, which is responsible for the clinical symptoms of malaria.
For transmission to a new host via a mosquito, the parasite needs to undergo sexual differentiation into
male or female gametocytes. The development of the gametocytes encompasses five morphologically
distinct stages and takes approximately 12 days in P. falciparum [56]. In contrast, gametocytes of
the rodent malaria parasites P. berghei and P. yoelii only differentiate in 48 h. It is presumed that all
gametocytes that originate from one schizont develop into the same sex [57]. A mosquito can finally
ingest the mature gametocytes during a blood meal. Conditions in the mosquito midgut trigger
gametogenesis and male and female gametes egress from the blood cells (reviewed in [58]). During
this process, the male gametocytes rapidly divide into eight microgametes that exflagellate and then
fertilise the female macrogametes, forming a motile zygote called ookinete. The ookinete undergoes
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meiosis and it is the only polyploid phase of the parasite life cycle [59]. The ookinete then exits through
the peritrophic membrane and migrates across the midgut wall to settle on the other side as an oocyst
(reviewed in [60]). Inside the oocyst, the parasite again asexually propagates until a generation of
new sporozoites is released, which migrate to the mosquito’s salivary glands to be secreted with the
next bite.
The heteroxenous parasite T. gondii is mainly transmitted by the ingestion of contaminated food or
water. Humans can be either infected by ingestion of tissue cysts that are present in undercooked meat,
or by faecal/oral transmission of sporulated oocysts shed by the feline definite host. Diaplacental
transmission also occurs, which is why first time infection during pregnancy can have detrimental
effects on the unborn baby. The sexual cycle of T. gondii takes place in the intestine of a feline
definitive host, where the bradyzoites that are released from ingested tissue cysts invade gut epithelial
cells and then undergo schizogony and gametogenesis. Fertilization results in the formation of a
sporulated oocyst, which is shed in the faeces and can be taken up by an intermediate host (including
humans), in which the asexual cycle takes place. There, the sporozoites that are released from the
oocysts differentiate into fast replicating asexual cells, called tachyzoites, which can invade almost any
nucleated cell, leading to their dissemination into other tissues, such as brain, muscles, or placenta.
The parasites can then differentiate into nearly dormant and slowly replicating bradyzoites, which
form a tissue cyst and represent a transmission stage, either back to the definitive host or another
intermediate host [61].
Cryptosporidia have a similar life cycle to Plasmodium or Toxoplasma, however they are monoxenous,
as transmission occurs via ingestion from the environment. In their life cycle, the asexual sporulated
thick-walled oocyst is taken up and forms four sporozoites that invade gut epithelial cells [62], in which
the asexual cycle takes place. Within the epithelial cells, the sporozoites undergo merogony to form
type I meronts (within 24 h after infection) that egress as merozoites (about 36 h post-infection) and
re-infect new gut epithelial cells. Subsequently, the merozoites undergo a second cycle of merogony to
form either type I meronts again, or type II meronts, which undergo gametogenesis to form micro-
and macrogametes [63]. These fertilise and form the zygote, which further develops either into the
thick-walled oocyst that is shed into the environment or into the thin-walled oocyst that auto-infects
the gut cells [62].
In the following paragraphs, we would like to review what is known regarding the regulation of
the transcriptome by ApiAP2 TFs during these life cycle transitions of apicomplexan parasites.
5. ApiAP2s of Malaria Parasites
5.1. Asexual Stages
During the intra-erythrocytic developmental cycle (IDC) of P. falciparum, gene expression occurs
in a regulated, cascading manner, so that each gene is only expressed during a restricted time frame [6].
This is also true for ApiAP2 TFs, which suggests that ApiAP2 expression during the IDC induces a
regulatory cascade that results in sequential activation of ApiAP2 TFs. In support of this concept,
binding motifs for many ApiAP2 TFs are present upstream of other ApiAP2 genes [33]. Systematic
knock out studies in the rodent malaria parasites P. berghei and P. yoelii have consistently identified ten
ApiAP2 TF members as being refractory to gene disruption, indicating that they might be essential
during the IDC (Table 1) [64–66]. However, several targeted studies have recently shed light on the
functions of selected ApiAP2 proteins during intra-erythrocytic growth.
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Table 1. ApiAP2 TFs in Plasmodium spp.
P.
falciparum
ApiAP2 TF
Name Orthologin P. vivax
Ortholog in P.
berghei
Ortholog
in P. yoelii
Mutated in P.
falciparum
[67]
Disrupted
in P.
berghei
Disrupted
in P. yoelii
[66]
Phenotype
(-| Block)
Motif
Recognized
[33,34]
Further
Ref
1 PF3D7_0404100 AP2-SP2 PVX_001040 PBANKA_1001800 PY17X_1003200 yes yes [65] yes oocyst -|sporoblast
2 PF3D7_0420300 PVX_090110 PBANKA_0521700 PY17X_0523100 refractory refractory[64,65] yes n.a.
CACACAC,
GTGTTACAC
3 PF3D7_0516800 AP2-O2 PVX_080410 PBANKA_1231600 PY17X_1235000 yes yes [64,65] yes zygote -|ookinete TGACATCA
4 PF3D7_0604100 SIP2 PVX_113370 PBANKA_0102900 PY17X_0104500 yes refractory[64,65] refractory n.a. GGTGCAC [36]
5 PF3D7_0611200 PVX_113695 PBANKA_0109500 PY17X_0111100 yes yes [64] refractory slowgrowth
6 PF3D7_0613800 PVX_113825 PBANKA_0112100 PY17X_0113700 refractory refractory[64,65] refractory n.a.
ATAAGCCCA,
CTCTAGAG
7 PF3D7_0622900AP2-Tel/SP3 PVX_114260 PBANKA_1121800 PY17X_1123200 yes yes [65] yes
sporozoites
-| liver
stage
[68,69]
8 PF3D7_0730300 AP2-L PVX_081810 PBANKA_0214400 PY17X_0215800 yes yes[64,65,70] refractory
sporozoites
-| liver
stage
AATTTCC [70]
9 PF3D7_0802100 n.a. PBANKA_1228100 PY17X_1231600 refractory refractory[64,65] refractory n.a. CACACACA
10 PF3D7_0934400 PVX_086995 PBANKA_0835200 PY17X_0838600 refractory refractory[64,65] refractory n.a.
11 PF3D7_1007700 AP2-I PVX_094580 PBANKA_1205900 PY17X_1209100 refractory refractory[65] refractory n.a.
GGGTCGACCC
TCTTGCC
GTGCACTA
[37]
12 PF3D7_1107800 PVX_091065 PBANKA_0939100 PY17X_0941600 refractory refractory[64,65] refractory n.a. AGCATAC
13 PF3D7_1115500 PVX_091420 PBANKA_0932300 PY17X_0934300 refractory yes [64,65] refractory n.a.
14 PF3D7_1139300 PVX_092570 PBANKA_0909600 PY17X_0911000 yes refractory[64,65] refractory n.a. TAGAACAA
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Mutated in P.
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in P. yoelii
[66]
Phenotype
(-| Block)
Motif
Recognized
[33,34]
Further
Ref
15 PF3D7_1143100 AP2-O PVX_092760 PBANKA_0905900 PY17X_0907300 refractory yes[64,65,71] yes
ookinete -|
oocyst
TAGCTA
[71] [71]
16 PF3D7_1222400 PVX_123750 n.a. n.a. yes n.a. n.a. n.a. TATATATA
17 PF3D7_1222600 AP2-G PVX_123760 PBANKA_1437500 PY17X_1440000 yes yes[64,65,72] yes
asexual -|
gametocyte
GxGTACxC
[72] [72,73]
18 PF3D7_1239200 PVX_100910 PBANKA_1453700 PY17X_1456200 refractory refractory[65] refractory n.a. TCTA(C/T)AA
19 PF3D7_1305200 PVX_122095 PBANKA_1403700 PY17X_1405400 yes refractory[64,65] refractory n.a. TGCACACAC
20 PF3D7_1317200 AP2-G3 PVX_122680 PBANKA_1415700 PY17X_1417400 yes refractory[65] yes
asexual -|
gametocyte TAGCTCA(G/A)A[74]
21 PF3D7_1342900 PVX_083040 PBANKA_1356000 PY17X_1361700 yes refractory[65] refractory n.a. GCGGGGC [69]
22 PF3D7_1350900 AP2-O4 PVX_083440 PBANKA_1363700 PY17X_1369400 refractory yes [64,65] yes ookinete -|oocyst ATTCTAGAA [75]
23 PF3D7_1408200 AP2-G2 PVX_086035 PBANKA_1034300 PY17X_1036700 yes yes [64,65,72,76] yes
asexual -|
gametocyte
GTTG(T/C)
[76] [72,76]
24 PF3D7_1429200 AP2-O3 PVX_085085 PBANKA_1015500 PY17X_1017000 yes yes [65] yes zygote -|ookinete [77]
25 PF3D7_1449500 AP2-O5 PVX_118015 PBANKA_1313200 PY17X_1317000 refractory refractory[64] yes
zygote -|
ookinete
26 PF3D7_1456000 PVX_117665 PBANKA_1319700 PY17X_1323500 yes yes [64,65] yes dispensable CACACACAC
27 PF3D7_1466400 AP2-SP/EXP PVX_117145 PBANKA_1329800 PY17X_1334500 yes yes[64,65,78] refractory
oocyst -|
sporoblast TGCATGCA [31,79]
28 n.a. AP2-Q PVX_080355 n.a. n.a. n.a. n.a. n.a. n.a. [80,81]
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AP2-I (PF3D7_1007700) encodes a 190 kDa protein with three AP2-domains, an AT-hook, and the
ACDC domain. AP2-I is the only ApiAP2 TF in which the ACDC domain is located in the N-terminal
region [33,82]. Five acetyl-lysine sites were found in AP2-I, of which two lay in the AP2 domains
AP2-D1 (K555) and AP2-D2 (K804). The mutation of K804 to glutamine resulted in a loss of specific
DNA binding by the AP2-D2, indicating that neutralization of the positive charge by acetylation may
provide a regulatory mechanism to relieve DNA binding [82]. This was similar to previous reports on
DNA-binding of TF in other organisms.
All three AP2 domains of AP2-I are associated with different DNA motifs (Table 1) [33]. The DNA
binding motif of its AP2-D3, GTGCAC, is enriched upstream of many schizont expressed genes with
putative functions in erythrocyte invasion [33,83–85], implicating AP2-I in invasion gene regulation.
Indeed, chromatin immunoprecipitation, followed by deep sequencing (ChIPseq), confirmed that
AP2-I associates with many invasion gene promoters [37]. This interaction was independent of the
other two AP2 domains, as the mutation of critical residues in these domains had no effect on AP2-I
binding or AP2-I target gene expression. Interestingly, AP2-I binds its own promoter, suggesting that
it may enhance its own expression. Five other ApiAP2 TFs with expression peaks immediately after
AP2-I during the IDC were also targets of AP2-I, as consistent with the regulation of developmental
progression by an AP2 TF cascade [37]. In several studies, AP2-I was found in complex with
acetyl-lysine binding bromodomain proteins (PfBDP1 and PfBDP2) and other chromatin remodelling
factors [37,38,86]. Intriguingly, AP2-I binding precedes the recruitment of the bromodomain protein
PfBDP1, which is also critical for invasion gene regulation [86]. Thus, AP2-I likely exerts its regulatory
function by inducing chromatin remodelling and recruiting the transcriptional machinery; however,
a complete understanding of the molecular details requires further investigations.
Another ApiAP2 TF that has been indirectly linked to the process of invasion is the 485 kDa
PF3D7_0613800. PF3D7_0613800 expression peaks in the late trophozoite to schizont stage and it
was identified by mass spectrometry as an interaction partner of PfBDP1 [37,86]. The pull down of
all three proteins with a novel DNA motif that was identified by ATACseq as accessible to DNA
binding proteins, further supported the connection between PF3D7_0613800, AP2-I, and PfBDP1 [38].
In the same study, Pf3D7_0613800 was pulled down as the only TF binding to the DNA motif
GAGCTCAA. Interestingly, this motif is different from the binding sites that were predicted for
two of its three AP2 domains [33], indicating that the third AP2 domain, for which no binding site was
previously predicted, might recognize this motif. In an ApiAP2 KO screen, the P. berghei orthologue
of PF3D7_0613800, PBANKA_0112100 was shown to be refractory to deletion, indicating that this
TF might be essential for blood stage replication [65]. Moreover, PF3D7_0613800 was implicated in
drug resistance, as mutations in amino acid Q197 of PF3D7_0613800 were associated with resistance to
three different MMV (Medicines for Malaria Venture) compounds in a chemogenetic screen that aimed
to identify novel drug resistance mechanisms [87]. Variants of this gene were also linked to quinine
resistance in a genome-wide association study [88], providing further evidence for a potential role of
Pf3D7_0613800 in the response to drugs. Further, PF3D7_0613800 was down-regulated upon re-entry
into the cell cycle following DFMO (difluoromethylornithine) induced cell cycle arrest, indicating that
it might also have a functional role during the G1 phase of the parasite cell cycle [89].
PfAP2-EXP (PF3D7_1466400) is a 92 kDa protein that contains a single AP2 domain and an
AT-hook site at its N-terminal end [79]. The acetylation of lysine 11 has been reported, however
the functional significance of this has not been established [79,82]. The DNA motif recognized by
PfAP2-EXP, TGCATGCA is the most overrepresented octamer in intergenic regions in Apicomplexan
genomes [90,91], including P. falciparum, T. gondii, C. parvum (where it is bound by cgd2_2490), and
Eimeria tenella [34]. Binding sites of PfAP2-EXP have been predicted upstream of the var gene family
members [33], but also upstream of most of the ApiAP2 genes [34]. While the complete disruption
of PfAP2-EXP failed, truncation produced viable parasites that showed an upregulation of members
of the clonally variant exported protein families PfMC-2TM, RIFIN, and STEVOR [79]. PfAP2-EXP
shares 92% identity in the AP2 domain with its P. berghei orthologue PbAP2-Sp, which was shown to
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be dispensable for asexual growth and has a function in sporozoites (discussed later) [78]. Thus, this
species-specific difference may rely on the more divergent C-terminus [79].
Unlike other ApiAP2 TFs, PfSIP2 (PF3D7_0604100) was implicated in heterochromatin formation
and genome integrity rather than transcriptional regulation [36]. The 230 kDa protein contains two
AP2-domains that are arranged in tandem at its N-terminus, and it is processed to an active 60 kDa
N-terminal fragment during schizogony. The AP2-D1 of PfSIP2 is sufficient for binding to the SPE2
motif [33,34,36], which is located in tandem arrays approximately 2 kb upstream of the subtelomeric
upsB-type var genes [36,92]. Orthologues of PfSIP2 can be found in all sequenced Plasmodium species,
such as P. berghei (PBANKA_0102900), P. yoelii (PY17X_0104500), as well as C. parvum (cdg4_3820).
However, subtelomeric SPE2 arrays are limited to P. falciparum, whereas in other species, SIP2 consensus
sequences are mainly located within chromosome internal regions, indicating that SIP2 likely has
additional functions to chromosome end biology. So far, SIP2 was refractory to deletion in P. falciparum
and rodent parasites; thus, PfSIP2 could be essential in parasite survival in the IDC [36,64,65]. The
overexpression of the N-terminal fragment of PfSIP2 had only marginal effects on gene expression,
further corroborating that its essential function is unlinked to transcriptional regulation [36].
Another ApiAP2 family member implicated in telomere biology is the protein that is encoded by
PF3D7_0622900, which was recently identified as a component of the P. falciparum telomere-binding
protein complex and thus dubbed PfAP2-Tel [68]. PfAP2-Tel is expressed throughout the
intra-erythrocytic developmental cycle (IDC), during which it co-localizes with telomeric clusters
at the nuclear periphery, which is consistent with its specific binding to the telomeric repeat motif
GGGTT(T/C)A on all 14 chromosomes of P. falciparum [68]. ApiAP2-Tel possesses an atypical AP2
domain with low sequence identity (<27%) to other members of the ApiAP2 family. This AP2 domain
lacks one of the three β-sheet structures, which are considered to be essential for DNA-binding [31],
but PfAP2-Tel binding to the telomeric repeat motif GGGTT(T/C)A was experimentally confirmed
in electro-mobility shift assays (EMSA). Interestingly, PfAP2-Tel was pulled down together with
PfBDP1 [86], providing another link between ApiAP2 TFs and chromatin modifications. The
orthologue of ApiAP2-Tel was successfully disrupted in rodent malaria parasites, indicating that
its function in asexual parasites is non-essential (see Section 5.3 for more details) [64–66].
5.2. Sexual Differentiation
To continue the life cycle and ensure the transmission of the parasite, a proportion of the
fast-proliferating asexual cells differentiate into dimorphic sexual forms—the male and female
gametocytes. Remarkably, the differentiation process in P. falciparum occurs in about 10 to 12 days,
whereas it is much faster in other Plasmodium species. The commitment step, which precedes
the differentiation, is associated with a transcriptional switch, which is mediated by the ApiAP2
TF AP2-G [50,72,73]. As the gametocytes can only propagate further inside the mosquito host,
the conversion rate is tightly regulated and it depends on environmental factors to which the parasites
can adapt. On the one hand, it was shown that the conversion rate in high transmission areas is lower
than in low transmission areas, which is probably due to selective pressure towards the optimisation of
transmission in these areas [93]. Additionally, commitment to sexual differentiation is a disadvantage
in asexual growth, as becomes clear from high mutation rates of AP2-G in culture and from AP2-G
knockout parasites, which outgrow their wildtype parents [65,72,94,95]. On the other hand, the
conditions in the vertebrate host also influence the conversion rate; for instance, high concentrations
of homocysteine, low levels of LysoPC (caused by high parasitemia), as well as other factors lead to
higher differentiation rates [96,97].
In P. falciparum, PfAP2-G (PF3D7_1222600) was initially found by comparing the transcriptional
variation in clones of two 3D7 stocks (3D7-A and 3D7-B) [98]. Until then, only a deletion in the
subtelomeric region of chromosome 9 or defects in several early gametocyte genes had been associated
with the disability to form gametocytes [74,99,100]. However, the region on chromosome 9 was
present in the two non-gametocyte forming strains F12 and A4, and genome sequencing revealed
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that only a single gene carried nonsense mutations in both of the strains. In line with a role in
gametocyte differentiation, the expression of this gene was predictive for the number of gametocytes
that were produced in the two 3D7 clones, so this factor was named PfAP2-G [73,101]. In parallel
AP2-G was identified in P. berghei non-gametocyte producing cells [72]. Since then, AP2-G has been
studied extensively and it has been shown to be a key regulator of gametocytogenesis, meaning
that its activation leads to the activation of the differentiation program, which is in line with up to
70% gametocyte conversion rates upon conditional AP2-G overexpression in P. berghei [102]. AP2-G
contains only one AP2 domain and it is expressed early in sexually committed cells and in stage
I gametocytes [33,50,72,73,103]. However, in committed parasites, expression occurs after some
other gametocyte specific genes, like GEXP5 [50,104], indicating that AP2-G is not the first factor
deciding sexual fate. Nevertheless, it was recently demonstrated that, if expression occurs early
enough (before 12 h post invasion in P. berghei, or before 20 h post invasion in P. falciparum), initiation
of the differentiation process is possible within the same cell cycle [102,105]. In non-committed
cells, the AP2-G locus is epigenetically silenced but may be stochastically activated [106]. The
epigenetic silencing is mediated by PfHda2 (Histone deacetylase 2) and by chromatin binding of
the Heterochromatin Protein 1 (HP1), which is removed through a mechanism involving the protein
GDV1 (gametocyte development 1) upon commitment [99,107–109]. This was also supported by a
three-dimensional chromatin confirmation capture study (Hi-C), where the AP2-G locus was found
to be located within a cluster of repressed var genes in asexual stages, from where it left upon
commitment [110]. After de-repression, AP2-G can recognise the (Gx)GTACNC motif in the upstream
region of its target genes [34,72,103]. This motif is also eight-fold present in the upstream region (2.1 kb
to 3.6 kb) of AP2-G itself, leading to a positive feedback loop that enhances the expression of AP2-G
and then triggers the subsequent transcriptional changes [72,73,103,111]. Josling et al., 2019, recently
elucidated the target genes of AP2-G by ChIP-seq. As expected, it was found to bind to the promoter
regions of many early gametocyte genes. However, surprisingly, it also bound to the promoter regions
of invasion genes, especially in committed schizont stage parasites. The binding motif of AP2-G is
similar to the GTGCAC motif that was recognised by AP2-I and the direct interaction of AP2-G with
AP2-I seems to enhance its function. Among the shared targets of AP2-G and AP2-I, there were also
other ApiAP2 TFs, including PF3D7_1239300, SIP2, and PF3D7_1107800. Despite the binding of several
invasion related promoters, MSRP1 was the only invasion gene that was specifically upregulated
by AP2-G, which may potentially be a reason for reticulocytes being a preferred invasion target for
committed merozoites [103]. Interestingly, cooperative interaction between different ApiAP2 TFs was
also shown in T. gondii between TgAP2XI-5 and TgAP2X-5, which will be discussed later [112].
This type of regulation of the commitment to transmission seems to be conserved in Plasmodium,
but also in their close relatives, for example, the bovine apicomplexan parasite Theileria annulata.
In T. annulata, it was shown that the orthologue of AP2-G, TaAP2.g (TA13515), binds the same
motif GxCTACxC, which is enriched in the upstream regions of genes that were expressed
during differentiation of the sexual transmission stages [113]. In addition, the orthologue of the
uncharacterised Plasmodium ApiAP2 TF PF3D7_0802100, TaAP2.me1 (TA11145), was found to bind to
the (A)CACAC(A) motif (the same motif as its orthologue and also the uncharacterised Plasmodium
ApiAP2 TFs PF3D7_0420300 and PF3D7_1305200), and it probably plays a role in the commitment in
T. annulata, as it is upregulated during differentiation in comparison to parasites that are incapable of
differentiating [113].
In addition to AP2-G, another ApiAP2 TF, AP2-G2, with functions during gametocytogenesis,
has been identified in P. berghei (PBANKA_1034300). As its name suggests, this factor is believed to
function downstream of AP2-G, as knockout nearly completely diminishes gametocyte production
(>95%), but, in contrast to AP2-G knockout parasites, these mutants are unable to outgrow their
parents [65,72]. Thus, P. berghei AP2-G2 knockout parasites still commit to sexual development and
their sex, but they mostly fail to mature, and the few parasites that morphologically differentiate into
gametocytes cannot exflagellate and cannot be transmitted to mosquitoes [72,76]. In ChIP-Seq analyses,
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it was shown that AP2-G2 binds to the GTTG(T/C) motif (and the reverse complementary form) of
about 1500 predicted target genes, including genes from the asexual, mosquito, and liver stages [76].
Among these genes, the interaction of AP2-G2 with the upstream regions of MSP1 and MSP7 was
confirmed by EMSA (electrophoretic mobility shift assay) [76]. Upon knockout of AP2-G2, its target
genes were found to be upregulated, suggesting a role for AP2-G2 in gene repression rather than gene
activation [76]. Consistent with this proposed function as repressor, the knock out of the P. berghei
orthologue resulted not only in a block in gametocyte maturation, but also in the derepression of
sexual stage genes in schizont stage parasites [65].
Recently, AP2-G3 (PY17X_1417400) has been identified in a CRISPR/Cas9 mediated knock out
study in P. yoelii as a third gametocyte related ApiAP2 factor [66]. The P. falciparum orthologue
(PF3D7_1317200) was also implicated in gametogenesis in a piggyback mutagenesis approach,
screening for mutations that disrupted the formation of gametocytes [74]. Although its name suggests
a role downstream of AP2-G and AP2-G2, it is indeed supposed to act upstream of AP2-G [66]. This
is, as, on the one hand, it was shown to be expressed in asexual parasites as well as in gametocytes
and it is localised in both the nucleus and in the cytoplasm, so it was proposed to act as a sensor of
environmental signals and pose the switch triggering AP2-G regulation [66]. On the other hand, its
knockout leads to a loss of gametocyte formation and a decrease in AP2-G expression [66]. Accordingly,
a possible hypothesis could be that AP2-G3 senses environmental signals, like homocysteine, LysoPC,
and others, and then activates AP2-G, which in turn initiates the differentiation process by activating
gametocyte specific genes, while AP2-G2 acts as a repressor for asexual gene expression during the
differentiation process. Of note, the P. vivax orthologue of AP2-G3, PVX_122680, was implicated in
altered gene regulation in developing drug resistance [114,115].
Furthermore, there are several other ApiAP2 TFs that seem to be implicated in gametocytogenesis
in P. falciparum. Directly after initial AP2-G expression, PF3D7_1222400 is upregulated, and during
peak AP2-G expression, the PF3D7_1139300 is also highly expressed [111]. This is in line with the
findings of Chaubey et al., who studied the transcriptomic response to ER stress induced by DTT that
triggers gametocytogenesis. In this analysis, a cascade of upregulated ApiAP2 TFs was found, with
expression of the unknown ApiAP2 PF3D7_1342900 preceding expression of ApiAP2 PF3D7_1139300
and 8 other genes, which was then followed by the upregulation of 23 other genes, including AP2-L
(PF3D7_0730300) and ApiAP2 PF3D7_0420300, whereof the latter poses a positive feedback loop for
all three other ApiAP2 factors [116]. However, in this cascade of regulated genes, neither AP2-G nor
AP2-G2 or AP2-G3 was identified—nevertheless, they reported that the formation of gametocytes was
enhanced. This hints to an involvement of metabolic cues for the upregulation of other ApiAP2 factors
that again regulate one of the interaction partners of the ApiAP2 genes that leads to an enhancement
of AP2-G transcription.
Female gametocytes, as well as the oocysts and sporozoites, were shown to store transcripts that
are needed for the later stages [117,118]. This translational repression is mediated, among others,
by Puf2 (pumilio family), DOZI (DDX-6 class DEAD box RNA helicase), and CITH (Sm-like factor
homolog of CAR-I and Trailer Hitch) [119]. In P. berghei, the repressed mRNAs were found to carry
a 47bp long, U-rich sequence in the 3′ or 5′ UTR of the mRNA, which is absent in P. falciparum [119].
Some ApiAP2 TFs were shown to be already transcribed in gametocytes, but their knockout affects later
stages [65,66]. Among those are PF3D7_1305200, PF3D7_1107800, SIP2, AP2-SP2 (PF3D7_0404100),
and AP2-O [118]. Of those, AP2-O was downregulated in DOZI KO and CITH KO in P. berghei [117].
5.3. Gametogenesis and Sporogony
Once the gametocytes are taken up by a mosquito, they differentiate into micro- and
macrogametes, which fuse to form the zygote. The zygote then develops into the motile ookinete
that crosses the midgut wall and settles on the other side, where finally sporogony is initiated inside
the oocyst. These steps are again associated with changes in gene expression, which also involve
ApiAP2 TFs [49,120]. The first ookinete specific ApiAP2 that was characterised in P. berghei was
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termed AP2-O (PBANKA_0905900). This factor was essential for the normal morphology of the
ookinete and the formation of oocysts [35,66,71]. Interestingly, knockout also attenuated asexual
growth, indicating that AP2-O may also play a role during the IDC [65]. AP2-O is transcribed in the
female gametocytes and subsequently stored in a complex with the RNA helicase DOZI (development
of zygote inhibited) [71,117]. Around 8 h after the fertilisation of the macrogamete, the translation
of AP2-O is initiated [71]. AP2-O then activates its target genes, which carry the TAGCTA motif
or its reverse complement in their promoter, although similar sequences can also be bound [71].
Genome-wide ChIP analysis revealed that AP2-O targets about 500 genes, which belong to the GO
(gene ontology) term categories of pellicle formation and midgut infection, as well as genes that are
involved in oocyst development [35].
The knockdown of four other ApiAP2 TFs also had effects from the ookinete stage onwards
in P. berghei or P. yoelii: AP2-O2 (PBANKA_1231600), AP2-O3 (PBANKA_1015500), AP2-O4
(PBANKA_1363700), and AP2_O5 (PY17X_1317000) [65,66]. Of those, ApiAP2-O2 was found
to be expressed throughout the asexual cycle and sexual differentiation until the oocyst stage
in P. yoelii [66]. Knockout of ApiAP2-O2 led to misshaped ookinetes in P. berghei but normal
ookinetes in P. yoelii, respectively; however, both parasite knockout lines were unable to differentiate
further [65,66]. In contrast to that, AP2-O3 is not found in asexual stages or ookinetes, but was
sex-specifically expressed in female gametocytes as well as in zygotes and oocysts in P. falciparum and
rodent malaria parasites [66,110]. Its knockout completely abrogates normal ookinetes and further
development [65,66,110]. Furthermore, upon AP2-O3 disruption, the genes known to be translationally
repressed in female gametocytes were already deregulated in the gametocyte stage [65]. This suggested
a role of AP2-O3 in the regulation of genes that are needed for the release of transcriptionally
repressed genes [66]. Similar to AP2-O3, AP2-O4 is only expressed in the sexual and mosquito
stages; however, its disruption does not affect ookinete development or motility but blocks oocyst
and further differentiation [65,66]. Finally, PyAP2-O5 (PY17X_1317000) is expressed in schizonts,
gametocytes, and zygotes, but not in ookinetes in P. yoelii. The knockout of PyAP2-O5 indicates that it
plays a role in ookinete motility and is therefore essential for oocyst development [66].
Inside the oocyst, Plasmodium parasites propagate by undergoing sporogony. Sporozoites
eventually egress and migrate to the salivary glands. In this stage, specific gene regulation is achieved
via ApiAP2 TFs designated AP2-Sp. The first AP2-Sp (PBANKA_1329800) was identified in P. berghei.
It was shown to be expressed in the late oocyst to sporozoite stage and to recognise the TGCATG(CA)
motif with its AP2 domain and adjacent AT-hook [78]. The motif is present in all known sporozoite
genes and, in line with that, AP2-Sp knock out leads to a loss of sporogony in the oocyst and the
upregulation of gametocyte-specific genes [65,78]. Interestingly, the AP2-Sp motif is also present
in the upstream region of PF3D7_0420300, an uncharacterised ApiAP2 factor, suggesting a possible
regulatory interaction [78]. Intriguingly, the PbAP2-Sp KO parasites also showed attenuated growth in
asexual parasites [65]. As is consistent with a function in asexual stages, PbAP2-Sp is the orthologue of
the P. falciparum TF that was designated PfAP2-exp, which has a role in the regulation of subtelomeric
gene families (see section on asexual stages) [79]. In line with this function it could be shown that
in sporozoites generated from clinical isolates from Burkina Faso a single var gene, PF3D7_1255200,
which carries the DNA motif recognised by PfAP2-EXP, is transcribed [120].
Recently, AP2-Sp2 and AP2-Sp3 were also identified in P. berghei and P. yoelii [65,66]. AP2-Sp2 was
shown to be involved in sporozoite formation in the oocyst, as knockout led to a block of development
in the sporoblast stage [65,66]. For the knockout of AP2-Sp3, sporogony was not affected; however,
the sporozoites were not motile and it could not exit the oocyst, so they failed to reach the salivary
glands and to mature completely [64–66]. Interestingly, the orthologue of PbAP2-Sp3 was recently
described as PfAP2-Tel in P. falciparum (as discussed in Section 5.1). In the future, it will be interesting to
investigate whether PbAP2-Sp3 also associates with telomeres in rodent malaria parasites, and whether
this may be linked to the observed motility phenotype.
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Additionally, further ApiAP2 TFs may be implicated in sporozoite development. The two ApiAP2
TFs PBANKA_0521700/PY17X_0523100 and PBANKA_1319700/PY17X_1323500 are expressed in
sporozoites, but the knockout showed no distinct phenotype [66]. However, the P. falciparum
orthologues both bind the CACACA motif, which possibly indicates the redundancy of these
factors [33]. Furthermore, remodelling of the chromatin structure in sporozoites was marked by
long-range and interchromosomal contacts of several genes, including the AP2 TF PF3D7_1107800 as
well as genes implicated in the liver stage [110].
In C. parvum, the ApiAP2 TF cgd4_1110, which is the orthologue of some of the sexual
stage-specific factors in P. falciparum—like ApiAP2-O2, ApiAP2-O5, ApiAP2-Sp, and others—is not
expressed during the asexual part of the life cycle. However, about 48 h to 72 h post infection,
when sexual parasites have developed, cgd4_1110 is transcribed, which indicates that it is specifically
expressed in the sexual stages [63]. In sporozoites of Cryptosporidium, the TFs cgd6_2600 and cgd8_3230,
which is orthologous to several sporozoite and oocyst specific P. falciparum ApiAP2 TFs, were found to
be upregulated [40]. This shows that there seems to be a similar cascade of transcriptional regulation
in Cryptosporidium sexual stages as in Plasmodium, however the complexity is reduced due to the
redundancy of the factors.
5.4. Liver Stages
Once the sporozoites have reached the liver with the blood circulation, they invade hepatocytes
via Kupffer cells, where they start to propagate into merozoites (reviewed in [121]). AP2-L (ortholog
of PF3D7_0730300) is the only stage-specific TF that has been so far implicated in this process.
AP2-L is expressed in the trophozoites and sporozoites of P. falciparum and P. berghei [49,70], and the
transcript levels are also high in P. vivax sporozoites [81]. After liver infection, the PbAP2-L levels
increased until 36 h after infection and subsequently decreased again until 48 h after infection [70].
Knockout leads to normal invasion of the sporozoites into the hepatocytes, however their development
is disturbed. 24 h after infection, the cells differ in size, and from 36 h after infection onwards,
the nuclear division is arrested [65,70]. AP2-L was predicted to recognise the motif AATTTCC and 11
putative target genes, which are mostly implicated in host cell remodelling, could be identified [33,70].
In liver stage parasites, ApiAP2-L was down-regulated by the KO of the sporozoite protein SLARP
(Sporozoite and LS asparagine-rich protein) (PF3D7_1147000), which is implicated in liver stage
specific transcript storage and stabilisation in the sporozoite, suggesting the translational regulation
of AP2-L expression [70,122–124]. Another ApiAP2 TF that may possibly be involved in liver stage
gene regulation is the uncharacterised PF3D7_1139300, which recognises the TAGAACA motif [125].
This motif was identified in a mutagenesis assays of the promoter sequence of the liver stage specific
gene LISP2 (PF3D7_0405300) [125]. The mutation of the motif showed enhanced gene expression,
suggesting a potential role of PF3D7_1139300 binding to this motif in gene repression [125].
A few Plasmodium species have the capability of forming dormant stages in the liver, which can
be reactivated after up to several years of quiescence [126]. In these species, including P. vivax or the
simian parasite P. cynomolgi, another ApiAP2 TF was identified that had no orthologue in P. falciparum
and the rodent Plasmodium species. Therefore this TF was implicated in the biology of the quiescent
hypnozoite stages and was named AP2-Q (PCYB_102390, PVP01_1016100). Indeed, a comparison of
the transcriptomic data from P. cynomolgy hypnozoites and liver schizonts displayed higher expression
of AP2-Q in hypnozoites [80], but in another study there was no evidence for the differential regulation
of AP2-Q in P. cynomolgi [127], and AP2-Q transcripts were only detected at very low levels in these
stages in P. vivax [128]. However, AP2-Q was transcribed but not translated in sporozoites, indicating
that it might be translationally repressed in sporozoites and only translated upon liver infection [81].
Another factor, encoded by PVP01_0916300 was upregulated in P. vivax hypnozoites relative to
liver schizonts [128], and this TF was also highly expressed in P. vivax sporozoites [81]. In contrast,
PvAP2-L showed similar expression levels in the dormant and active liver stage parasites [128].
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In P. cynomolgy hypnozoites, AP2-O2 and AP2-G2 were also upregulated relative to liver schizonts,
however the function of these proteins in this stage is unclear [80].
6. ApiAP2 Transcription Factors in Toxoplasma
The tachyzoite cycle represents the asexual part of the life cycle of T. gondii, which can be
divided into the G1 and S/M phase. The switch to bradyzoite development occurs in the S/M
phase (reviewed by [129]). 24 different ApiAP2 TFs showed distinct expression patterns throughout
tachyzoite development, indicating that they may have a role in the timing of gene expression during
cell cycle progression, similar to Plasmodium [41].
The mutation of the nuclear factor Cactin arrests the parasites in the G1 phase at 40 ◦C,
and transcriptional analysis identified several ApiAP2s that were specifically upregulated, namely
TgAP2X-7, TgAP2VIIa-6, TgAP2XII-4, and TgAP2VIII-4 (Table 2) [130]. These data may indicate that
these factors are important for suppressing cell cycle progression to S-phase. Another TF, TgAP2XI-5,
is expressed throughout the tachyzoite cell cycle and it was implicated in the regulation of virulence
genes (among others) during the S/M phase by binding to the palindromic GCTAGC motif [112,131].
Interestingly, TgAP2XI-5 was found to interact with TgAP2X-5, which is most prevalent during the
S/M phase of the cell cycle [112]. The disruption of TgAP2X-5 leads to a dramatic decrease in virulence,
accompanied by the deregulation of several virulence genes and reduced invasion but normal growth.
However, chromatin immunoprecipitation failed to show the direct binding of TgAP2X-5 to the
deregulated genes, although TgAP2XI-5 binding to several of the deregulated genes was diminished
in the TgAP2X-5 deleted line. This suggests that the cooperation of both factors is needed for efficient
regulation—possibly through the formation of heterodimers for motif recognition [112].
Similar to P. falciparum, the ApiAP2 TFs of T. gondii also interact with chromatin associated factors.
Four ApiAP2 TFs (TgAP2IX-7, TgAP2X-8, TgAP2XI-2, and TgAP2XII-4) were co-precipitated with the
histone acetyltransferase GCN5b, which is essential for normal parasite growth [132].
In T. gondii, the switch from the fast-replicating asexual tachyzoite to the nearly dormant cyst
forming bradyzoite, which is often induced by alkaline stress, is essential for transmission to the feline
host, where sexual replication takes place. Several ApiAP2 with activating and suppressing functions
for this process have been identified. Upon alkaline stress, TgAP2IX-9 is induced [133], which binds
the CAGTGT motif [134]. The knockout of TgAP2IX-9 enhanced tissue cyst formation, whereas the
overexpression disrupted tissue cyst formation, suggesting a role for TgAP2IX-9 in bradyzoite gene
repression [133,134]. In line with this, TgAP2IX-9 was upregulated in a parasite strain that showed
higher alkaline stress resistance in comparison to more sensitive isolates [135]. TgAP2IV-4, which is
expressed in the late tachyzoite phases, was also associated with a repressive function. While knockout
did not affect asexual growth, it lead to the expression of bradyzoite specific genes in tachyzoites [136].
Another ApiAP2 factor, TgAP2IX-4 is dynamically expressed in tachyzoites and early bradyzoites [137].
The knockout of TgAP2IX-4 did not affect tachyzoite proliferation, but lead to the reduced formation
of tissue cysts. Transcriptional profiling indicated that TgAP2IX-4 might act via the repression of
bradyzoite specifc genes during the early stages of bradyzoites formation, which is possibly restricted
to a population of replicating cells within the tissue cyst [137].
After the peak expression of TgAP2IX-9, TgAP2IV-3 is upregulated, which possibly competes
for the control of bradyzoite gene expression [133,134]. Later in bradyzoite development, TgAP2XI-4,
which induces bradyzoite formation, could replace TgAP2IX-9 [134]. TgAP2XI-4 has been implicated
in bradyzoite development and cyst formation upon alkaline stress, as the knockout did not affect
tachyzoite growth but inhibited cyst formation [131]. The CACACAC motif is a putative binding site
of TgAP2XI-4, and two zinc finger proteins were identified as the possible downstream targets [131].
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Table 2. ApiAP2 TFs in T. gondii.
AP2 Name Function/Phenotype Interactions
1 TGME49_208020 AP2Ib-1
2 TGME49_252370 AP2III-1
3 TGME49_253380 AP2III-2
4 TGME49_299150 AP2III-3
5 TGME49_299020 AP2III-4
6 TGME49_320700 AP2IV-1
7 TGME49_320680 AP2IV-2
8 TGME49_318610 AP2IV-3 Control of bradyzoite genes [133,134]
9 TGME49_318470 AP2IV-4 KO leads to expression of bradyzoitespecific genes in tachyzoites [136]
10 TGME49_211720 AP2IV-5
11 TGME49_267460 AP2IX-1
12 TGME49_264485 AP2IX-3
13 TGME49_288950 AP2IX-4 KO leads to reduces tissue cystformation [137]
14 TGME49_289710 AP2IX-5
15 TGME49_290180 AP2IX-6
16 TGME49_290630 AP2IX-7 Implicated in cell cycle progression toS-phase [130] GCN5b [132]
17 TGME49_306000 AP2IX-8
18 TGME49_306620 AP2IX-9 KO enhances cyst formation, alkalinestress response [133,134]
19 TGME49_220530 AP2V-1
20 TGME49_285895 AP2V-2
21 TGME49_240460 AP2VI-1
22 TGME49_240900 AP2VI-2
23 TGME49_244510 AP2VI-3
24 TGME49_280470 AP2VIIa-1
25 TGME49_280460 AP2VIIa-2
26 TGME49_205650 AP2VIIa-3
27 TGME49_203710 AP2VIIa-4
28 TGME49_203690 AP2VIIa-5
29 TGME49_203050 AP2VIIa-6 Implicated in cell cycle progression toS-phase [130]
30 TGME49_202490 AP2VIIa-7
31 TGME49_282210 AP2VIIa-8
32 TGME49_282220 AP2VIIa-9
33 TGME49_262420 APVIIb-1/ADA2-B
34 TGME49_262000 AP2VIIb-2
35 TGME49_255220 AP2VIIb-3
36 TGME49_229370 AP2VIII-1
37 TGME49_233120 AP2VIII-2
38 TGME49_273660 AP2VIII-3
39 TGME49_272710 AP2VIII-4 Implicated in cell cycle progression toS-phase [130]
40 TGME49_271200 AP2VIII-5
41 TGME49_271030 AP2VIII-6
42 TGME49_269010 AP2VIII-7
43 TGME49_227900 AP2X-1
44 TGME49_225110 AP2X-2
45 TGME49_224230 AP2X-3
46 TGME49_224050 AP2X-4
47 TGME49_237090 AP2X-5 Implicated in virulence generegulation [112] AP2XI-5 [112]
48 TGME49_237425 AP2X-6
49 TGME49_214840 AP2X-7 Implicated in cell cycle progression toS-phase [130]
50 TGME49_214960 AP2X-8 GCN5b [132]
51 TGME49_215150 AP2X-9
52 TGME49_215340 AP2X-10
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Table 2. Cont.
AP2 Name Function/Phenotype Interactions
53 TGME49_215570 AP2X-11
54 TGME49_309410 AP2XI-1
55 TGME49_310900 AP2XI-2 GCN5b [132]
56 TGME49_310950 AP2XI-3
57 TGME49_315760 AP2XI-4 KO inhibits cyst formation [131,134]
58 TGME49_216220 AP2XI-5 Implicated in virulence generegulation [112] AP2X-5 [112]
59 TGME49_215895
AP2
domain-containing
protein
60 TGME49_218960 AP2XII-1
61 TGME49_217700 AP2XII-2
62 TGME49_246660 AP2XII-3
63 TGME49_247700 AP2XII-4 Implicated in cell cycle progression toS-phase [130] GCN5b [132]
64 TGME49_247730 AP2XII-5
65 TGME49_249190 AP2XII-6
66 TGME49_250800 AP2XII-8
67 TGME49_251740 AP2XII-9
7. Conclusions
The recent publication of numerous studies addressing ApiAP2 function represents a major
advance in our understanding of their diverse roles in apicomplexan biology. It is now very well
established that ApiAP2s indeed represent the regulatory factors that direct the transcriptional switches
that underlie the multiple transitions into morphologically distinct differentiation stages during the
life cycles of apicomplexan parasites. ApiAP2 factors clearly have both activating and repressive
roles in gene expression, and their interaction with chromatin binding proteins indicates that one
of the mechanisms through which they exert regulatory functions is by recruiting the chromatin
modifying complexes to target gene promoters [37,86,132]. Highly specific gene regulation, despite
some redundancy in binding motifs of ApiAP2 TFs in Plasmodium and Cryptosporidium, may be
achieved by the documented combinatorial action of several ApiAP2 TFs with each other [38,103,112].
The discovery of auto-regulatory loops [73] and the identification of modulatory acetylations in
ApiAP2 domains [82] provide mechanisms that contribute to the regulation of ApiAP2 function.
In addition to the well documented role of ApiAP2s in gene regulation, some ApiAP2 TFs, namely
SIP2 and PfAP2-Tel, have been implicated in chromosome end biology [36,68]. Future investigations
are expected to shed light on the molecular mechanisms that underlie the regulatory function of
ApiAP2 TFs, for example, how they direct the transcriptional machinery, how they contribute to
chromatin remodelling, how they interact with one another to achieve transcriptional control, or how
post-translational modifications can modulate their function.
Recently, researchers have begun to exploit the regulatory function of ApiAP2 TFs as a tool for
manipulating gene expression in apicomplexan parasites. In one study, engineered promoters carrying
ApiAP2 recognition sites (termed “Spooki”) were used to redirect the timing of gene expression in
Plasmodium ookinetes and sporozoites [138,139]. In another study, the transactivation domains of
several AP2 TFs were employed in a tetracycline-dependent system to direct artificial gene regulation
in T. gondii and P. berghei [138,139].
The lack of human orthologues and the essentiality for asexual and sexual differentiation
makes ApiAP2 TFs very attractive drug targets. In T. gondii, the targeting of AP2XI-3 with
phosphorodiamidate morpholine oligomers coupled to transductive peptides that carry small
molecules over various membranes inhibited gene expression in a sequence specific manner, resulting
in diminished parasite replication in vitro and in vivo in a mouse infection model [140]. Thus,
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the exploitation of the essential function of ApiAP2 TFs appears as a promising strategy for novel
therapeutic approaches.
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